Cargando…

Craspase: A novel CRISPR/Cas dual gene editor

Detalles Bibliográficos
Autores principales:	Huo, George, Shepherd, Jennings, Pan, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034874/ https://www.ncbi.nlm.nih.gov/pubmed/36952053 http://dx.doi.org/10.1007/s10142-023-01024-0

Ejemplares similares

Structural basis for the non-self RNA-activated protease activity of the type III-E CRISPR nuclease-protease Craspase
por: Cui, Ning, et al.
Publicado: (2022)

CRISPR–Cas12a base editors confer efficient multiplexed genome editing in rice
por: Cheng, Yanhao, et al.
Publicado: (2023)

Metagenomic discovery of novel CRISPR-Cas13 systems
por: Hu, Yanping, et al.
Publicado: (2022)

CRISPR/ddCas12a-based programmable and accurate gene regulation
por: Wang, Jingman, et al.
Publicado: (2019)

CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
por: Shahzad, Faizan, et al.
Publicado: (2022)

Hypercompact CRISPR–Cas12j2 (CasΦ) enables genome editing, gene activation, and epigenome editing in plants
por: Liu, Shishi, et al.
Publicado: (2022)

CRISPR-Cas12a-assisted nucleic acid detection
por: Li, Shi-Yuan, et al.
Publicado: (2018)

Implications of CRISPR/Cas9 system in Hypertension and its related diseases
por: Sekar, Durairaj, et al.
Publicado: (2020)

Reprogrammable CRISPR/dCas9-based recruitment of DNMT1 for site-specific DNA demethylation and gene regulation
por: Lu, Anrui, et al.
Publicado: (2019)

Genetic variation may confound analysis of CRISPR-Cas9 off-target mutations
por: Wang, Guanqun, et al.
Publicado: (2018)

Type I-F CRISPR–Cas provides protection from DNA, but not RNA phages
por: Buyukyoruk, Murat, et al.
Publicado: (2019)

CRISPR-Cas9-mediated editing of the OsHPPD 3′ UTR confers enhanced resistance to HPPD-inhibiting herbicides in rice
por: Wu, Yunyu, et al.
Publicado: (2023)

Response to “Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation”
por: Yang, Hui, et al.
Publicado: (2021)

Response to correspondence on “Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation”
por: Gurumurthy, Channabasavaiah B., et al.
Publicado: (2021)

Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a
por: Swartjes, Thomas, et al.
Publicado: (2020)

Elimination of Cas9-dependent off-targeting of adenine base editor by using TALE to separately guide deaminase to target sites
por: Liu, Yang, et al.
Publicado: (2022)

Disabling of ARC1 through CRISPR–Cas9 leads to a complete breakdown of self-incompatibility responses in Brassica napus
por: Abhinandan, Kumar, et al.
Publicado: (2022)

To the editor
por: Kebebew, Electron, et al.
Publicado: (2017)

Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity
por: DiEuliis, Diane, et al.
Publicado: (2017)

Efficient CRISPR-Cas9 based cytosine base editors for phytopathogenic bacteria
por: Li, Chenhao, et al.
Publicado: (2023)

Letter to the Editor
por: Narayan, Ishir
Publicado: (2023)

Letter to the Editor
por: Dharmadhikari, Ashwin S., et al.
Publicado: (2011)

Editor's Note
Publicado: (1988)

Letter to Editor
por: Şahan, Ekrem, et al.
Publicado: (2017)

Letter to the Editor
por: Goldsborough, Sarah
Publicado: (2018)

Editor’s note
por: Houck, Max
Publicado: (2021)

Letter to Editor
por: Saks, Michael J.
Publicado: (2021)

Letter to Editor
por: Ditrich, Hans
Publicado: (2021)

Cas9 has no exonuclease activity resulting in staggered cleavage with overhangs and predictable di- and tri-nucleotide CRISPR insertions without template donor
por: Shi, Xin, et al.
Publicado: (2019)

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications
por: Spalato-Ceruso, M, et al.
Publicado: (2023)

Letter to the Editor in Response to Zhou et al
por: Troth, Sean, et al.
Publicado: (2021)

CRISPR/Cas9-mediated knockout of intracellular molecule SHP-1 enhances tumor-killing ability of CD133-targeted CAR T cells in vitro
por: Liu, Ming, et al.
Publicado: (2023)

Efficient Genome Editing in Setaria italica Using CRISPR/Cas9 and Base Editors
por: Liang, Zhen, et al.
Publicado: (2022)

Response to Letter to the Editor
por: Adeniji, Folashayo, et al.
Publicado: (2023)

Reply to letter to the editor
por: Kvasnovsky, Charlotte L., et al.
Publicado: (2020)

Editor Dental Register
Publicado: (1886)

Letter to the editor: Reply
por: Shim, Jung-Woo, et al.
Publicado: (2021)

Response to Letter to the Editor
por: Mondal, Monidipa, et al.
Publicado: (2021)

Response to the letter to the editor
por: Olry de Labry Lima, Antonio, et al.
Publicado: (2021)

Response to letter to the editor
por: Sridharan, Aadhavi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7hvugimms2j321ek9hio382k53